Zai Lab Limited - ZLAB Company Short-Term Debt

Graphic logo of Zai Lab Corp (ZLAB)

Zai Lab Limited (ZLAB) unites leading scientists from the East and West through global development. An environmental approach to production and a social mission are supported by stability, as financial liabilities with a maturity of up to 12 months demonstrate that the indicator has reached the level of 0.26. Cost optimization is achieved through flexible outsourcing of clinical trials and contract drug manufacturing.

ZLAB (Zai Lab Ltd) Company Short-Term Debts history from 07/04/2022 to 10/28/2026

Zai Lab Corp - analytical breakdowns and key metrics (ZLAB)

- price and consensus price forecast:
Price Chart Zai Lab|ZLAB - Fair Value Consensus
- market capitalization data:
Market Value Zai Lab Limited|ZLAB - Real Price to Acquire Entire Company
- book capitalization data:
Book Value per Share Zai Lab|ZLAB - Book Capitalization|Market Cap to Net Assets Ratio zailaboratory.com|ZLAB - Aggregate Asset Value
- debt and liquidity data:
Total Debt to Capital Zai Lab Limited|ZLAB - Long-Term Debt to Capital Coefficient|Short-Term Debt to Equity Zai Lab Limited|ZLAB - Company Cumulative Debt|Debt to Book Capitalization Ratio Zai Lab Limited|ZLAB - Company Long-Term Debt|Company Short-Term Debts Zai Lab
Fundamental company valuation:ZLAB - Zai Lab
Signature product of Zai Lab Limited

Portfolio managers evaluate the operating model of Zai Lab Limited (ZLAB) through the lens of liquidity, where short-term debts measure the total borrowings maturing within one year to monitor solvency. An analysis of the company's short-term liability structure reveals how effectively the expansion of Western drugs in China is being financed, confirming business resilience while scaling the commercial network within the oncology sector.

Competitors of Zai Lab Limited (ZLAB)

Company Short-Term Debt Eli Lilly (LLY)|ABBV: Company Short-Term Loans and Borrowings|AZN (AstraZeneca AB) - Company Short-Term Debt|Novartis Pharma (NVS) - Company Current Liabilities|MRK (Merck & Co., Inc.) - Company Short-Term Debts|Company Short-Term Debts novonordisk.com (NVO)|Amgen (AMGN) - Company Current Liabilities|Company Short-Term Loans and Borrowings Pfizer Inc (PFE)|Company Short-Term Debts Sanofi Aventis|Bristol-Myers Squibb Co. - Company Short-Term Loans and Borrowings|GSK (GSK Corp) - Company Short-Term Debt|TAK: Short-Term Debt|Teva Pharma (TEVA) - Company Short-Term Debt|Dr. Reddy's Laboratories Limited (RDY) - Company Short-Term Debt|Company Short-Term Debts Viatris Corp (VTRS)|Company Short-Term Indebtedness Roivant Corp|BHC (Bausch Health Companies) - Company Short-Term Debts|Short-Term Debt Volume COSM (cosmosholdingsinc.com)